SEC Form 4 · accession 0001144204-16-088671
Harvard Apparatus Regenerative Technology, Inc. · HRGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Blaine H. McKee
Director
Period of report
Mar 15, 2016
Accepted (ET)
Mar 17, 2016 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001563665
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.84 | Mar 15, 2016 | A | 25,000 | A | Mar 15, 2017 | Mar 15, 2026 | Common Stock, par value $0.01 per share | 25,000 | 25,000 | D |
Explanation of responses
- F1The option shares vest in full one year from the date of grant.
Remarks
This form has been signed under power of attorney.